Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06606106
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-27
Brief Title:
A Study of LY3537031 in Overweight Obese and Healthy Participants
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multiple-Ascending Dose Study to Investigate the Safety Pharmacokinetics and Pharmacodynamics of LY3537031 in Overweight and Obese Participants and Healthy Volunteers
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 3-part study that includes a Part A Part B and Part C Part A will study the safety and tolerability of the study drug known as LY3537031 in participants who are overweight and obese Part B and Part C will study the safety and tolerability of LY3537031 in healthy participants Part C will contain only Japanese and Chinese healthy participants
Blood tests will be performed to check how much LY3537031 gets into the bloodstream and how long it takes the body to eliminate it Body weight will be measured The study will last approximately 20 weeks excluding a screening period
Blood tests will be performed to check how much LY3537031 gets into the bloodstream and how long it takes the body to eliminate it Body weight will be measured The study will last approximately 20 weeks excluding a screening period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None